159 related articles for article (PubMed ID: 31411865)
1. Engineering Biocoatings To Prolong Drug Release from Supraparticles.
Ma Y; Cortez-Jugo C; Li J; Lin Z; Richardson RT; Han Y; Zhou J; Björnmalm M; Feeney OM; Zhong QZ; Porter CJH; Wise AK; Caruso F
Biomacromolecules; 2019 Sep; 20(9):3425-3434. PubMed ID: 31411865
[TBL] [Abstract][Full Text] [Related]
2. Gel-Mediated Electrospray Assembly of Silica Supraparticles for Sustained Drug Delivery.
Ma Y; Björnmalm M; Wise AK; Cortez-Jugo C; Revalor E; Ju Y; Feeney OM; Richardson RT; Hanssen E; Shepherd RK; Porter CJH; Caruso F
ACS Appl Mater Interfaces; 2018 Sep; 10(37):31019-31031. PubMed ID: 30192499
[TBL] [Abstract][Full Text] [Related]
3. Developing the supraparticle technology for round window-mediated drug administration into the cochlea.
Gunewardene N; Ma Y; Lam P; Wagstaff S; Cortez-Jugo C; Hu Y; Caruso F; Richardson RT; Wise AK
J Control Release; 2023 Sep; 361():621-635. PubMed ID: 37572963
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica supraparticles for sustained inner-ear drug delivery.
Wang Y; Wise AK; Tan J; Maina JW; Shepherd RK; Caruso F
Small; 2014 Nov; 10(21):4244-8. PubMed ID: 25099026
[TBL] [Abstract][Full Text] [Related]
5. Sustained Protein Release from a Core-Shell Drug Carrier System Comprised of Mesoporous Nanoparticles and an Injectable Hydrogel.
Manavitehrani I; Fathi A; Schindeler A; Dehghani F
Macromol Biosci; 2018 Dec; 18(12):e1800201. PubMed ID: 30395416
[TBL] [Abstract][Full Text] [Related]
6. Supramolecular cyclodextrin pseudorotaxane hydrogels: a candidate for sustained release?
Chee PL; Prasad A; Fang X; Owh C; Yeo VJ; Loh XJ
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():6-12. PubMed ID: 24863190
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biodistribution of supraparticle-delivered neurotrophin 3 in the guinea pig cochlea.
Gunewardene N; Lam P; Ma Y; Caruso F; Wagstaff S; Richardson RT; Wise AK
J Control Release; 2022 Feb; 342():295-307. PubMed ID: 34999140
[TBL] [Abstract][Full Text] [Related]
8. Multi-arm PEG/silica hydrogel for sustained ocular drug delivery.
Lu C; Zahedi P; Forman A; Allen C
J Pharm Sci; 2014 Jan; 103(1):216-26. PubMed ID: 24285503
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a newly developed HPMC ophthalmic insert with sustained release properties as a carrier for thermolabile therapeutics.
Everaert A; Broeckx G; Fransen E; Ludwig A; Kiekens F; Weyenberg W
Int J Pharm; 2015 Mar; 481(1-2):37-46. PubMed ID: 25623490
[TBL] [Abstract][Full Text] [Related]
10. Sustained protein release from hydrogel microparticles using layer-by-layer (LbL) technology.
Sakr OS; Jordan O; Borchard G
Drug Deliv; 2016 Oct; 23(8):2747-2755. PubMed ID: 26289209
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional poly(lactic-co-glycolic acid)/silica colloidal crystal microparticles for sustained drug release and visualized monitoring.
Guo R; Sun XT; Zhang Y; Wang DN; Yang CG; Xu ZR
J Colloid Interface Sci; 2018 Nov; 530():465-472. PubMed ID: 29990782
[TBL] [Abstract][Full Text] [Related]
12. Drug depot-anchoring hydrogel: A self-assembling scaffold for localized drug release and enhanced stem cell differentiation.
Li R; Pang Z; He H; Lee S; Qin J; Wu J; Pang L; Wang J; Yang VC
J Control Release; 2017 Sep; 261():234-245. PubMed ID: 28694033
[TBL] [Abstract][Full Text] [Related]
13. Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model.
Ullah S; Seidel K; Türkkan S; Warwas DP; Dubich T; Rohde M; Hauser H; Behrens P; Kirschning A; Köster M; Wirth D
J Control Release; 2019 Jan; 294():327-336. PubMed ID: 30586597
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Imaging of the Stability and Sustained Cargo Release of an Injectable Amphipathic Peptide-Based Hydrogel.
Oyen E; Martin C; Caveliers V; Madder A; Van Mele B; Hoogenboom R; Hernot S; Ballet S
Biomacromolecules; 2017 Mar; 18(3):994-1001. PubMed ID: 28192660
[TBL] [Abstract][Full Text] [Related]
15. Designing novel macroporous composite hydrogels based on methacrylic acid copolymers and chitosan and in vitro assessment of lysozyme controlled delivery.
Dragan ES; Cocarta AI; Gierszewska M
Colloids Surf B Biointerfaces; 2016 Mar; 139():33-41. PubMed ID: 26700231
[TBL] [Abstract][Full Text] [Related]
16. Poloxamine/fibrin hybrid hydrogels for non-viral gene delivery.
Zhang J; Sen A; Cho E; Lee JS; Webb K
J Tissue Eng Regen Med; 2017 Jan; 11(1):246-255. PubMed ID: 24889259
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-loaded hydrogels as a pathway for enzyme-triggered drug release in ophthalmic applications.
Åhlén M; Tummala GK; Mihranyan A
Int J Pharm; 2018 Jan; 536(1):73-81. PubMed ID: 29180255
[TBL] [Abstract][Full Text] [Related]
18. Titania coating of mesoporous silica nanoparticles for improved biocompatibility and drug release within blood vessels.
Farooq A; Shukur A; Astley C; Tosheva L; Kelly P; Whitehead D; Azzawi M
Acta Biomater; 2018 Aug; 76():208-216. PubMed ID: 29933106
[TBL] [Abstract][Full Text] [Related]
19. Chitosan hydrogels incorporating colloids for sustained drug delivery.
Peers S; Montembault A; Ladavière C
Carbohydr Polym; 2022 Jan; 275():118689. PubMed ID: 34742416
[TBL] [Abstract][Full Text] [Related]
20. Lipogels responsive to near-infrared light for the triggered release of therapeutic agents.
Martín-Saavedra F; Ruiz-Hernández E; Escudero-Duch C; Prieto M; Arruebo M; Sadeghi N; Deckers R; Storm G; Hennink WE; Santamaría J; Vilaboa N
Acta Biomater; 2017 Oct; 61():54-65. PubMed ID: 28801266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
